A Prospective Study of Drug Approval Process in European Union Via Centralised Procedure (From 2015-2018)

Author(s): Navya Sri B *, Sai Sindhu P, Koushik Y and Ramarao N

Abstract: The current scenario of this article mainly highlights about the medicinal products that are highly synchronized in European Union. Medicinal products undergo an elaborate system of approvals that governs how, when, where, and in what form such products will be authorised to be sold within European Union. The current marketing authorization procedures that are applicable to European Economic Area include 28 European member states and 3 European Free Trade Association states. This article mainly emphasizes on centralised marketing procedure, decentralized procedure, mutual recognition procedure, and national procedure in European Union.

PAGES: 195-203  |  203 VIEWS  314 DOWNLOADS